STOKStoke Therapeutics, Inc.

Nasdaq stoketherapeutics.com


$ 11.99 $ 0.41 (3.53 %)    

Thursday, 09-May-2024 15:59:55 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 12.01
$ 11.76
$ 0.00 x 0
$ 0.00 x 0
$ 11.61 - $ 12.08
$ 3.35 - $ 16.40
313,190
na
555.43M
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-09-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-23-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-stoke-therapeutics-lowers-price-target-to-20

Canaccord Genuity analyst Sumant Kulkarni maintains Stoke Therapeutics (NASDAQ:STOK) with a Buy and lowers the price target ...

 hc-wainwright--co-reiterates-buy-on-stoke-therapeutics-maintains-35-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $35 price t...

 needham-reiterates-buy-on-stoke-therapeutics-maintains-22-price-target

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $22 price target.

 stoke-therapeutics-q1-2024-gaap-eps-057-beats-061-estimate-sales-4216m-beat-3214m-estimate

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(...

 stoke-therapeutics-appoints-thomas-leggett-as-chief-financial-officer-succeeds-stephen-tulipano-who-resigned-his-position-as-stokes-cfo-effective-tuesday-may-7

– Mr. Leggett brings more than two decades of experience as an investment banker and corporate executive leading financial stra...

 needham-reiterates-buy-on-stoke-therapeutics-maintains-22-price-target

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $22 price target.

 cantor-fitzgerald-reiterates-overweight-on-stoke-therapeutics

Cantor Fitzgerald analyst Charles Duncan reiterates Stoke Therapeutics (NASDAQ:STOK) with a Overweight.

 whats-going-on-with-stoke-therapeutics-stock-tuesday

After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of...

 crude-oil-moves-lower-td-synnex-earnings-top-estimates

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0...

 why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

 dow-gains-100-points-mccormick-posts-upbeat-results

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0...

 nasdaq-gains-over-50-points-us-durable-goods-orders-rise-in-february

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION